Description and predictive factors of infection in patients with chronic kidney disease admitted to the critical care unit

Journal of Infection

Volumn 68, Issue 2, 2014, Pages 105-115

  Contou, Damien ^a   d'Ythurbide, Géraldine ^a   Messika, Jonathan ^a   Ridel, Christophe ^a   Parrot, Antoine ^a   Djibré, Michel ^a   Hertig, Alexandre ^a   Rondeau, Eric ^a   Fartoukh, Muriel ^a  

^a HÔPITAL TENON   (France)

Author keywords

Chronic kidney disease; Epidemiology; Fever; Haemodialysis; Infection; Intensive care unit; Multidrug resistant bacterial colonization; Procalcitonin

Indexed keywords

PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORE TEMPERATURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PSEUDOMONAS INFECTION;

CHRONIC KIDNEY DISEASE; EPIDEMIOLOGY; FEVER; HAEMODIALYSIS; INFECTION; INTENSIVE CARE UNIT; MULTIDRUG-RESISTANT BACTERIAL COLONIZATION; PROCALCITONIN;

BACTERIAL INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84892437455     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.10.003     Document Type: Article

References (44)

1. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc 2007, 298:2038-2047.
2. Nielsen L.H., Jensen-Fangel S., Jespersen B., Ostergaard L., Sogaard O.S. Risk and prognosis of hospitalization for pneumonia among individuals with and without functioning renal transplants in denmark: a population-based study. Clin Infect Dis 2012, 55:679-686.
3. Naqvi S.B., Collins A.J. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 2006, 13:199-204.
4. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, etal. US Renal Data System 2010 Annual data report. Am J Kidney Dis 57:A8, e1-526.
5. Vanholder R., Ringoir S., Dhondt A., Hakim R. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991, 39:320-327.
6. Vanholder R., Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 1993, 3:1541-1554.
7. Lim W.H., Kireta S., Leedham E., Russ G.R., Coates P.T. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int 2007, 72:1138-1148.
8. Eleftheriadis T., Antoniadi G., Liakopoulos V., Kartsios C., Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial 2007, 20:440-451.
9. Sarnak M.J., Jaber B.L. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001, 120:1883-1887.
10. Sarnak M.J., Jaber B.L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000, 58:1758-1764.
11. Strijack B., Mojica J., Sood M., Komenda P., Bueti J., Reslerova M., et al. Outcomes of chronic dialysis patients admitted to the intensive care unit. J Am Soc Nephrol 2009, 20:2441-2447.
12. Hutchison C.A., Crowe A.V., Stevens P.E., Harrison D.A., Lipkin G.W. Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2007, 11:R50.
13. Manhes G., Heng A.E., Aublet-Cuvelier B., Gazuy N., Deteix P., Souweine B. Clinical features and outcome of chronic dialysis patients admitted to an intensive care unit. Nephrol Dial Transplant 2005, 20:1127-1133.
14. Bell M., Granath F., Schon S., Lofberg E., Ekbom A., Martling C.R. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome. Crit Care Med 2008, 36:2773-2778.
15. Jones P.G., Kauffman C.A., Port F.K., Kluger M.J. Fever in uremia: production of leukocytic pyrogen by chronic dialysis patients. Am J Kidney Dis 1985, 6:241-244.
16. Garrell S.L. Hypothermia in uremia. N Engl J Med 1970, 283:1001.
17. Hakim R.M., Lowrie E.G. Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials. Nephron 1982, 32:32-39.
18. Hoenich N.A., Johnston S.R., Woffindin C., Kerr D.N. Haemodialysis leucopenia: the role of membrane type and re-use. Contrib Nephrol 1984, 37:120-128.
19. Owen W.F., Lowrie E.G. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998, 54:627-636.
20. Haubitz M., Schulze M., Koch K.M. Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transplant 1990, 5:500-503.
21. Dahaba A.A., Rehak P.H., List W.F. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003, 29:579-583.
22. Visvardis G., Griveas I., Fleva A., Giannakou A., Papadopoulou D., Mitsopoulos E., et al. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients. Ren Fail 2005, 27:429-434.
23. Herget-Rosenthal S., Klein T., Marggraf G., Hirsch T., Jakob H.G., Philipp T., et al. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol 2005, 61:180-186.
24. Level C., Chauveau P., Delmas Y., Lasseur C., Pelle G., Peuchant E., et al. Procalcitonin: a new marker of inflammation in haemodialysis patients?. Nephrol Dial Transplant 2001, 16:980-986.
25. Akbulut H., Celik I., Ozden M., Dogukan A., Bulut V. Plasma procalcitonin levels in chronic haemodialysed patients. Turk J Med Sci 2005, 241-244.
26. Honkanen E., Gronhagen-Riska C., Teppo A.M., Maury C.P., Meri S. Acute-phase proteins during hemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes. Nephron 1991, 57:283-287.
27. Kaysen G.A., Stevenson F.T., Depner T.A. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997, 29:658-668.
28. Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
29. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
30. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
31. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
32. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
33. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related organ failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
34. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified acute Physiology score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 1993, 270:2957-2963.
35. Peduzzi P., Concato J., Kemper E., Holford T.R., Feinstein A.R. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49:1373-1379.
36. Hosmer D.W., Lemeshow S. Applied logistic regression 1989, John Wiley and Sons, New-York.
37. Egan J.P. Signal detection theory and ROC analysis 1975, Academic Press, New-York.
38. Berman S.J., Johnson E.W., Nakatsu C., Alkan M., Chen R., LeDuc J. Burden of infection in patients with end-stage renal disease requiring long-term dialysis. Clin Infect Dis 2004, 39:1747-1753.
39. Razazi K., Derde L.P., Verachten M., Legrand P., Lesprit P., Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 2012, 38:1769-1778.
40. Stenvinkel P., Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002, 15:329-337.
41. Kaysen G.A. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001, 12:1549-1557.
42. Meisner M., Lohs T., Huettemann E., Schmidt J., Hueller M., Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001, 18:79-87.
43. Meisner M., Schmidt J., Huttner H., Tschaikowsky K. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000, 26(Suppl. 2):S212-S216.
44. Lu X.L., Xiao Z.H., Yang M.Y., Zhu Y.M. Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis. Nephrol Dial Transplant 2013, 28:122-129.